SCHEMBL22021612

SCHEMBL22021612

COc1c(Cl)cc(Br)cc1Sn1c(-c2ccccc2)cc2cc(Cl)ccc21

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 19/20 0.46
▸ GRIK1 P39086 1/20 0.36
▸ GRIK2 Q13002 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22022211 0.79 ACLY (0.62) ACLY
SCHEMBL21954750 0.76 ACLY (0.73) ACLY
SCHEMBL22022216 0.69 ACLY (0.60) ACLY
SCHEMBL31333146 0.67 ACLY (0.44) ACLY
SCHEMBL8942357 0.66 KMT2A (0.66) ACLY
SCHEMBL21954738 0.63 ACLY (1.00) ACLY
SCHEMBL22003798 0.63 ACLY (0.44) ACLY
SCHEMBL22022196 0.63 KDM4E (0.46) ACLY
SCHEMBL8648612 0.63 GRIK1 (0.65) ACLYGRIK1GRIK2
SCHEMBL442742 0.61 ALDH1A1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102616-A1 ACLY INHIBITORS AND USES THEREOF Nimbus Artemis, Inc. (US) 2020-05-22 — — WO disclosed
Send feedback